Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Sesbania grandiflora improves hair growth and health.

Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.

Chronic stress increased after lockdown, especially in young adults and females.

Posterior column injuries are common in tibial plateau fractures, and CT imaging is crucial for accurate treatment planning.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Polarized microscopy helps identify hair irregularities in genetic disorders.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

ADAM17 could be a potential target for treating PCOS.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Microneedling is a promising, simple, and cost-effective treatment for hair loss that works well with other therapies.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.

The microbiome may be linked to hair loss and could be a target for new treatments.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Skin symptoms can indicate endocrine disorders and have various treatments.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Skin symptoms often reveal hormonal imbalances in PCOS.

Many college students experience mild hair loss, influenced by factors like gender, family history, and lifestyle, suggesting a need for health education.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.